Cancer Centers in the News

The following links highlight some of the most up-to-date news from the 25 NCCN Member Institutions. The media coverage below includes major national news outlets, industry magazines, medical journals, and press releases.

The news is listed in reverse chronological order for ease of use.

November 19, 2014
“Study Shows Link Between Genes, Seaside Vacations & Future Melanoma Risk,” University of Colorado Cancer Center

A longitudinal study established a link between different ultraviolet (UV) exposure measures in children, such as the number of waterside vacations or sunburns, and biomarkers of melanoma risk, such as the number of freckles or moles that develop during childhood, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

This story features commentary from an investigator at University of Colorado Cancer Center—one of the 25 NCCN Member Institutions.

>View Article<



November 19, 2014
“Power behind ‘Master’ Gene for Cancer Discovered,” The University of Texas MD Anderson Cancer Center

A study at The University of Texas MD Anderson Cancer Center led by Mong-Hong Lee, Ph.D., a professor of molecular and cellular oncology, has demonstrated the significance of CSN6 in regulating Myc, which may very well open up a new pathway for treating and killing tumors. The study results are published in this month’s issue of Nature Communications.

The University of Texas MD Anderson Cancer Center is one of the 25 NCCN Member Institutions.   

>View Article<



November 19, 2014
“Moffitt Cancer Center Researchers Use Evolutionary Principles to Model Cancer Mutations, Discover Potential Therapeutic Targets,” Moffitt Cancer Center

Moffitt Cancer Center researchers are taking a unique approach to understanding and investigating cancer by utilizing evolutionary principles and computational modeling to examine the role of specific genetic mutations in the Darwinian struggle among tumor and normal cells during cancer growth.

Moffitt Cancer Center is one of the 25 NCCN Member Institutions.   

>View Article<



November 17, 2014
“Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs,” Memorial Sloan Kettering Cancer Center

A team of researchers from Memorial Sloan Kettering and elsewhere has gained new insights into how tumors develop resistance to targeted drugs. The findings suggest that adding additional drugs to the treatment regimen may provide a longer-lasting response and a greater benefit to patients.

Memorial Sloan Kettering Cancer Center is one of the 25 NCCN Member Institutions.  

>View Article<



November 17, 2014
“Potential Therapy Found for Incurable Pediatric Brain Tumor,” Robert H. Lurie Comprehensive Cancer Center at Northwestern University

Northwestern Medicine scientists have discovered a new potential drug therapy for a rare, incurable pediatric brain tumor by targeting a genetic mutation found in children with the cancer.

By inhibiting the tumor-forming consequences of the mutation using an experimental drug called GSKJ4, they delayed tumor growth and prolonged survival in mice with pediatric brainstem glioma.

Robert H. Lurie Comprehensive Cancer Center at Northwestern University is one of the 25 NCCN Member Institutions.  

>View Article<



November 12, 2014
"Gene Sequencing Projects Link Two Mutations to Ewing Sarcoma Subtype with Poor Prognosis," St. Jude Children’s Research Center/The University of Tennessee Health Science Center

An international collaboration has identified frequent mutations in two genes that often occur together in Ewing sarcoma (EWS) and that define a subtype of the cancer associated with reduced survival. The research, conducted by the St. Jude Children’s Research Hospital-Washington University Pediatric Cancer Genome Project and the Institut Curie-Inserm through the International Cancer Genome Consortium, appears in the current issue of the scientific journal Cancer Discovery.

St. Jude Children’s Research Center/The University of Tennessee Health Science Center is one of the 25 NCCN Member Institutions. 

>View Article<



November 11, 2014
"Cancer-Killing Virus Plus Chemotherapy Drug Might Treat Recurrent Ovarian Cancer," The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent. A new study suggests that a cancer-killing virus combined with a chemotherapy drug might safely and effectively treat advanced or recurrent forms of the disease.

 The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute is one of the 25 NCCN Member Institutions. 

>View Article<



November 11, 2014
"New Test Developed at Dana-Farber/Brigham and Women's Cancer Center Speeds Treatment Decisions for Blood Cancer Patients," Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

In a major advance in the care of these patients, physicians at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) have begun using Rapid Heme Panel, a high-tech genetic test that provides, within a matter of days, an unprecedented amount of critical information to aid the choice of treatment.

Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center is one of the 25 NCCN Member Institutions. 

>View Article<



November 10, 2014
"MD Anderson’s David M. Gershenson, MD, Receives IGCS’s Award for Excellence in Gynecologic Oncology," The University of Texas MD Anderson Cancer Center

For his myriad clinical, organizational and scientific accomplishments in the field of gynecologic oncology and the health and well-being of women, David M. Gershenson, M.D. has been recognized with the International Gynecology Cancer Society’s (IGCS) Award of Excellence.

The University of Texas MD Anderson Cancer Center is one of the 25 NCCN Member Institutions. 

>View Article<



November 10, 2014
"Promising Prognostic Biomarker Candidates for Ovarian Cancer Uncovered by Roswell Park Team," Roswell Park Cancer Institute

Cancer researchers at Roswell Park Cancer Institute (RPCI) have identified two independent classes of novel candidate prognostic markers for ovarian cancer, advancing efforts to develop targeted therapies for the disease. The findings resulted from two separate studies published in the peer-reviewed journal PLoS ONE and based on data from The Cancer Genome Atlas (TCGA), the world’s largest public database on gene expression in different tumor types.

Roswell Park Cancer Institute is one of the 25 NCCN Member Institutions. 

>View Article<



November 10, 2014
"Colorectal Cancer Rates Increasing for U.S. Adults Under 50," Oncology Nurse Advisor

While rates of colorectal cancer (CRC) have fallen among older Americans, cases among adults aged 20 to 49 are rising and expected to continue to do so, according to research from The University of Texas MD Anderson Cancer Center published online Nov. 5 in JAMA Surgery.

The University of Texas MD Anderson Cancer Center is one of the 25 NCCN Member Institutions. 

>View Article<



November 10, 2014
"Mayo Clinic Researchers Identify First Steps in Formation of Pancreatic Cancer," Mayo Clinic Cancer Center

Researchers at Mayo Clinic’s campus in Jacksonville say they have identified first steps in the origin of pancreatic cancer and that their findings suggest preventive strategies to explore.

Mayo Clinic Cancer Center is one of the 25 NCCN Member Institutions. 

>View Article<



November 9, 2014
"As U.S. Cases of Skin Cancer Rise, Costs Skyrocket, Too," Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Rising rates of skin cancer in the U.S. are taking a toll not only on the nation’s health, but on its wallet as well, a new federal study finds.

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance is one of the 25 NCCN Member Institutions.

>View Article<



November 9, 2014
"Yale Study: Medicare Costs for Breast Cancer Screenings Soar, but Benefits Remain Unclear," New Hampshire Register

The cost of Medicare-funded breast cancer screenings jumped 44 percent from $666 million to $962 million from 2001 to 2009, yet those added millions did not improve early detection rates among the 65 and older Medicare population, according to a Yale School of Medicine study published recently in the Journal of the National Cancer Institute.

Yale Cancer Center/Smilow Cancer Hospital is one of the 25 NCCN Member Institutions. 

>View Article<



November 7, 2014
"Researchers Take New Approach to Stop 'Most Wanted' Cancer Protein," Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center have found a way to defeat one of the most tantalizing yet elusive target proteins in cancer cells – employing a strategy that turns the protein’s own molecular machinations against it.

Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center is one of the 25 NCCN Member Institutions. 

>View Article<



November 6, 2014
"Dr. Candace Johnson Named Cancer Center Director at Roswell Park Cancer Institute," Roswell Park Cancer Institute

Candace S. Johnson, PhD, has been promoted to Cancer Center Director at Roswell Park Cancer Institute (RPCI), the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. In this new role with the Institute, she will manage the Institute’s Cancer Center Support Grant (CCSG) from the NCI as Principal Investigator and will oversee faculty recruitment and allocation of resources including space, personnel and institutional funds.

Roswell Park Cancer Institute is one of the 25 NCCN Member Institutions. 

>View Article<